Parkside Financial Bank & Trust’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$602K Sell
1,224
-158
-11% -$85.7K 0.05% 232
2025
Q4
$801K Buy
1,382
+92
+7% +$52K 0.06% 180
2025
Q3
$626K Buy
1,290
+312
+32% +$145K 0.05% 219
2025
Q2
$397K Sell
978
-195
-17% -$81.5K 0.04% 287
2025
Q1
$584K Buy
1,173
+134
+13% +$72.6K 0.07% 195
2024
Q4
$541K Sell
1,039
-27
-3% -$14.8K 0.07% 194
2024
Q3
$659K Sell
1,066
-3
-0.3% -$1.78K 0.09% 163
2024
Q2
$591K Buy
1,069
+57
+6% +$32.7K 0.09% 165
2024
Q1
$588K Buy
1,012
+127
+14% +$71.3K 0.09% 167
2023
Q4
$470K Sell
885
-122
-12% -$59.1K 0.09% 178
2023
Q3
$510K Buy
1,007
+13
+1% +$6.93K 0.12% 134
2023
Q2
$519K Sell
994
-35
-3% -$18.9K 0.12% 133
2023
Q1
$593K Buy
1,029
+37
+4% +$20.9K 0.16% 110
2022
Q4
$546K Buy
992
+106
+12% +$56.2K 0.16% 113
2022
Q3
$450K Buy
886
+7
+0.8% +$3.92K 0.14% 119
2022
Q2
$478K Sell
879
-52
-6% -$28.6K 0.15% 121
2022
Q1
$549K Sell
931
-121
-12% -$69.5K 0.15% 104
2021
Q4
$702K Buy
1,052
+468
+80% +$292K 0.17% 91
2021
Q3
$333K Buy
584
+34
+6% +$18.7K 0.1% 144
2021
Q2
$277K Buy
550
+41
+8% +$19.3K 0.08% 163
2021
Q1
$233K Buy
509
+9
+2% +$4.3K 0.07% 178
2020
Q4
$233K Buy
500
+9
+2% +$4.22K 0.07% 174
2020
Q3
$217K Sell
491
-74
-13% -$30.6K 0.08% 171
2020
Q2
$204K Buy
565
+7
+1% +$2.35K 0.07% 198
2020
Q1
$159K Buy
558
+63
+13% +$19.9K 0.06% 195
2019
Q4
$161K Buy
495
+15
+3% +$4.55K 0.05% 214
2019
Q3
$140K Sell
480
-28
-6% -$8.02K 0.05% 222
2019
Q2
$150K Buy
508
+2
+0.4% +$551 0.05% 216
2019
Q1
$139K Sell
506
-13
-3% -$3.23K 0.05% 216
2018
Q4
$116K Buy
519
+155
+43% +$36.4K 0.04% 229
2018
Q3
$89K Buy
364
+68
+23% +$15.6K 0.03% 275
2018
Q2
$61K Buy
296
+20
+7% +$4.25K 0.02% 318
2018
Q1
$57K Buy
276
+11
+4% +$2.31K 0.02% 320
2017
Q4
$50K Sell
265
-23
-8% -$4.41K 0.02% 361
2017
Q3
$54K Buy
288
+41
+17% +$7.42K 0.02% 332
2017
Q2
$43K Sell
247
-150
-38% -$25.2K 0.02% 364
2017
Q1
$61K Buy
397
+185
+87% +$28.3K 0.03% 295
2016
Q4
$30K Sell
212
-171
-45% -$25.2K 0.01% 438
2016
Q3
$61K Sell
383
-12
-3% -$1.85K 0.03% 318
2016
Q2
$58K Sell
395
-8
-2% -$1.18K 0.03% 316
2016
Q1
$57K Buy
403
+42
+12% +$5.63K 0.03% 307
2015
Q4
$51K Sell
361
-140
-28% -$18.7K 0.03% 321
2015
Q3
$62K Sell
501
-13,048
-96% -$1.7M 0.04% 272
2015
Q2
$1.76M Sell
13,549
-71
-0.5% -$9.26K 0.93% 22
2015
Q1
$1.83M Buy
13,620
+187
+1% +$24.1K 0.98% 22
2014
Q4
$1.68M Buy
13,433
+25
+0.2% +$3.04K 0.95% 21
2014
Q3
$1.63M Sell
13,408
-91
-0.7% -$11.1K 0.99% 24
2014
Q2
$1.59M Buy
13,499
+162
+1% +$19.1K 0.95% 26
2014
Q1
$1.6M Buy
+13,337
New +$1.59M 1% 25

Other funds holding TMO

Parkside Financial Bank & Trust's TMO Position: Q1 2026 in Review

Parkside Financial Bank & Trust reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q1 2026, selling an estimated $85.7K and leaving 1,224 shares worth $602K. The position accounts for 0.05% of the portfolio, ranked #232.

Parkside Financial Bank & Trust first reported a position in TMO in Q1 2014 and has held it in 49 quarters since. The position peaked at $1.83M in Q1 2015. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Parkside Financial Bank & Trust held 1,224 shares of Thermo Fisher Scientific worth $602K as of Q1 2026.
  • Parkside Financial Bank & Trust sold 158 Thermo Fisher Scientific shares in Q1 2026, an estimated $85.7K.
  • Thermo Fisher Scientific made up 0.05% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #232 holding.
  • Parkside Financial Bank & Trust first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 49 quarters since.
  • Parkside Financial Bank & Trust's Thermo Fisher Scientific position peaked at $1.83M in Q1 2015.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.